The content is available as a PDF (289.5 KB).
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) ; Scientific Opinion on the substantiation of health claims related to taurine and “immune system protection” (ID 611), “metabolism processes” (ID 613), contribution to normal cognitive function (ID 1659), maintenance of normal cardiac function (ID 1661), maintenance of normal muscle function (ID 1949) and delay in the onset of physical fatigue during exercise (ID 1958) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2035. [19 pp.]. doi: 10.2903/j.efsa.2011.2035.
Panel members: Carlo Agostoni, Jean‐Louis Bresson, Susan Fairweather‐Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser‐Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Correspondence: nda@efsa.europa.eu
Acknowledgement: The Panel wishes to thank for the preparatory work on this scientific opinion: The members of the Working Group on Claims: Carlo Agostoni, Jean‐Louis Bresson, Susan Fairweather‐Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. The members of the Claims Sub‐Working Group on Cardiovascular Health/Oxidative Stress: Antti Aro, Marianne Geleijnse, Marina Heinonen, Ambroise Martin, Wilhelm Stahl and Henk van den Berg. The members of the Claims Sub‐Working Group on Weight Management/Satiety/Glucose and Insulin Control/Physical Performance: Kees de Graaf, Joanne Harrold, Mette Hansen, Mette Kristensen, Anders Sjödin and Inge Tetens. The members of the Claims Sub‐Working Group on Mental/Nervous System: Jacques Rigo, Astrid Schloerscheidt, Barbara Stewart‐Knox, Sean (J.J.) Strain, and Peter Willatts.
Adoption date: 12 November 2010
Published date: 8 April 2011
Question number: EFSA‐Q‐2008‐1398, EFSA‐Q‐2008‐1400, EFSA‐Q‐2008‐2395, EFSA‐Q‐2008‐2397, EFSA‐Q‐2008‐2682, EFSA‐Q‐2008‐2691
On request from: European Commission
References
- Alford C, Cox H and Wescott R, 2001. The effects of red bull energy drink on human performance and mood. Amino Acids, 21, 139–150. [DOI] [PubMed] [Google Scholar]
- Azuma J, Sawamura A and Awata N, 1992. Usefulness of taurine in chronic congestive heart failure and its prospective application. Japanese Circulation Journal, 56, 95–99. [DOI] [PubMed] [Google Scholar]
- Kendler BS, 1989. Taurine: an overview of its role in preventive medicine. Preventive Medicine, 18, 79–100. [DOI] [PubMed] [Google Scholar]
- Lourenco R and Camilo ME, 2002. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutricion Hospitalaria, 17, 262–270. [PubMed] [Google Scholar]
- Raschke P, Massoudy P and Becker BF, 1995. Taurine protects the heart from neutrophil‐induced reperfusion injury. Free Radical Biology and Medicine, 19, 461–471. [DOI] [PubMed] [Google Scholar]
- Seidl R, Peyrl A, Nicham R and Hauser E, 2000. A taurine and caffeine‐containing drink stimulates cognitive performance and well‐being. Amino Acids, 19, 635–642. [DOI] [PubMed] [Google Scholar]
- Takahashi K, Schaffer SW and Azuma J, 1997. Taurine prevents intracellular calcium overload during calcium paradox of cultured cardiomyocytes. Amino Acids, 13, 1–11. [Google Scholar]
- Zhang M, Izumi I, Kagamimori S, Sokejima S, Yamagami T, Liu Z and Qi B, 2004. Role of taurine supplementation to prevent exercise‐induced oxidative stress in healthy young men. Amino Acids, 26, 203–207. [DOI] [PubMed] [Google Scholar]